150 related articles for article (PubMed ID: 32405870)
1. Health-Related Quality of Life in Antiphospholipid Syndrome: Current Knowledge and Future Perspectives.
Desnoyers M; Dufrost V; Wahl D; Zuily S
Curr Rheumatol Rep; 2020 May; 22(6):20. PubMed ID: 32405870
[TBL] [Abstract][Full Text] [Related]
2. Impairment of quality of life in patients with antiphospholipid syndrome.
Zuily S; Rat AC; Regnault V; Kaminsky P; Mismetti P; Ninet J; Baillet N; Magy-Bertrand N; Pasquali JL; Lambert M; Pasquier E; Lorcerie B; Lecompte T; Guillemin F; Wahl D;
Lupus; 2015 Oct; 24(11):1161-8. PubMed ID: 25862730
[TBL] [Abstract][Full Text] [Related]
3. Organ Damage and Quality of Life in Antiphospholipid Syndrome.
Alba P; Gómez-Puerta JA; Goycochea-Robles MV; Amigo MC
Curr Rheumatol Rep; 2016 Feb; 18(2):7. PubMed ID: 26769306
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQoL) using the SF-36.
Georgopoulou S; Efraimidou S; MacLennan SJ; Ibrahim F; Cox T
Lupus; 2015 Feb; 24(2):174-9. PubMed ID: 25239925
[TBL] [Abstract][Full Text] [Related]
5. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
6. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
[TBL] [Abstract][Full Text] [Related]
7. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
Zdrojewski Z
Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
[TBL] [Abstract][Full Text] [Related]
9. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
10. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
11. Thrombovascular events affect quality of life in patients with systemic lupus erythematosus.
Balitsky AK; Peeva V; Su J; Aghdassi E; Yeo E; Gladman DD; Urowitz MB; Fortin PR
J Rheumatol; 2011 Jun; 38(6):1017-9. PubMed ID: 21362766
[TBL] [Abstract][Full Text] [Related]
12. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A
Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
17. Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome.
Oki H; Aoki T; Saito K; Yamashita Y; Hanamiya M; Hayashida Y; Tanaka Y; Korogi Y
Eur J Radiol; 2012 Jun; 81(6):1335-9. PubMed ID: 21501937
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid Syndrome and the Kidney.
Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
20. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
